Prices are updated after-hours


Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date

symbols : BNTX    crawled date : 2020 - 12 - 14    save search

Pfizer and BioNTech Provide Data from German Phase 1/2 Study Further Characterizing Immune Response Following Immunization with Lead COVID-19 Vaccine Candidate BNT162b2
Published: 2020-12-14 (Crawled : 11:01) - globenewswire.com
PFE | News A | $26.32 0.23% 0.0% 24M twitter stocktwits trandingview |
Health Technology
| | O: 1.22% H: 0.1% C: -5.79%
BNTX | News | $88.53 0.59% 0.59% 360K twitter stocktwits trandingview |
Health Technology
| | O: -0.53% H: 0.29% C: -14.5%

covid vaccine phase 3 phase 1 phase 2 germany
Gainers vs Losers
78% 22%

Top 10 Gainers
MTTR | News M | $4.6 164.37% 62.17% 28M twitter stocktwits trandingview |

AGBA | $2.94 135.2% 57.48% 66M twitter stocktwits trandingview |
Finance

EDBL | News | $6.46 71.81% 41.8% 2M twitter stocktwits trandingview |

MTC | $2.25 44.23% 30.67% 6M twitter stocktwits trandingview |
Technology Services

OPRT | News | $3.175 41.11% 29.13% 12M twitter stocktwits trandingview |
Finance

SHIM | $3.05 35.56% 26.23% 1.1M twitter stocktwits trandingview |

HKIT | $1.345 31.86% 24.16% 390K twitter stocktwits trandingview |
Technology Services

ABVC | $1.36 30.77% 23.53% 7.4M twitter stocktwits trandingview |
Wholesale Trade

OST | $0.512 28.0% 21.88% 290K twitter stocktwits trandingview |

POET | $1.59 27.2% 21.38% 4.2M twitter stocktwits trandingview |
Manufacturing


Your saved searches
Save your searches and get alerts when important news are released.